Ipilimumab vs Midazolam

## Ipilimumab vs Midazolam: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Midazolam**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Midazolam**: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Midazolam — 1.5-2.5 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Midazolam — C18H13ClFN3.

**Molecular Weight**: Ipilimumab — N/A; Midazolam — 325.7670 g/mol.

**Type**: Ipilimumab — Antibody; Midazolam — Small molecule.